Are ChatGPT and large language models "the answer" to bringing us closer to systematic review automation?


Journal

Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575

Informations de publication

Date de publication:
29 04 2023
Historique:
received: 21 03 2023
accepted: 20 04 2023
medline: 1 5 2023
pubmed: 30 4 2023
entrez: 29 4 2023
Statut: epublish

Résumé

In this commentary, we discuss ChatGPT and our perspectives on its utility to systematic reviews (SRs) through the appropriateness and applicability of its responses to SR related prompts. The advancement of artificial intelligence (AI)-assisted technologies leave many wondering about the current capabilities, limitations, and opportunities for integration AI into scientific endeavors. Large language models (LLM)-such as ChatGPT, designed by OpenAI-have recently gained widespread attention with their ability to respond to various prompts in a natural-sounding way. Systematic reviews (SRs) utilize secondary data and often require many months and substantial financial resources to complete, making them attractive grounds for developing AI-assistive technologies. On February 6, 2023, PICO Portal developers hosted a webinar to explore ChatGPT's responses to tasks related to SR methodology. Our experience from exploring the responses of ChatGPT suggest that while ChatGPT and LLMs show some promise for aiding in SR-related tasks, the technology is in its infancy and needs much development for such applications. Furthermore, we advise that great caution should be taken by non-content experts in using these tools due to much of the output appearing, at a high level, to be valid, while much is erroneous and in need of active vetting.

Identifiants

pubmed: 37120563
doi: 10.1186/s13643-023-02243-z
pii: 10.1186/s13643-023-02243-z
pmc: PMC10148473
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

72

Informations de copyright

© 2023. The Author(s).

Références

Contemp Clin Trials Commun. 2019 Aug 25;16:100443
pubmed: 31497675
BMJ Open. 2017 Feb 27;7(2):e012545
pubmed: 28242767
Radiology. 2023 Apr;307(2):e230163
pubmed: 36700838
PLOS Digit Health. 2023 Feb 9;2(2):e0000198
pubmed: 36812645
J Med Libr Assoc. 2018 Apr;106(2):198-207
pubmed: 29632442

Auteurs

Riaz Qureshi (R)

University of Colorado Anschutz Medical Campus, Aurora, CO, USA. riaz.qureshi@cuanschutz.edu.
PICO Portal, New York, NY, USA. riaz.qureshi@cuanschutz.edu.

Daniel Shaughnessy (D)

University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Kayden A R Gill (KAR)

PICO Portal, New York, NY, USA.
University of Pittsburgh, Pittsburgh, PA, USA.

Karen A Robinson (KA)

PICO Portal, New York, NY, USA.
Johns Hopkins University, Baltimore, MD, USA.

Tianjing Li (T)

University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
PICO Portal, New York, NY, USA.

Eitan Agai (E)

PICO Portal, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH